Abstract Introduction: Cannabinoids hold promise in oncology for symptom relief and antitumor effects, though concerns about safety and efficacy persist.…
Abstract Cachexia–anorexia cancer syndrome remains an unmet clinical need with a dearth of treatment and no standard of care. Acting…
Abstract Cannabis enjoyed a “golden age” as a medicinal product in the late 19th, early 20th century, but the increased…
Abstract Introduction: Patients with head and neck cancer (HNC) are usually confronted with functional changes due to the malignancy itself…
Abstract Cancer‐associated cachexia (CAC) is a wasting syndrome characterized by involuntary weight loss and anorexia. Clear definition and diagnostic criteria…
Abstract Background: Cancer-related cachexia and anorexia syndrome (CACS) is a common phenomenon in cancer patients. Cannabis has been suggested to…
Abstract Background: Muscle wasting, anorexia, and metabolic dysregulation are common side‐effects of cytotoxic chemotherapy, having a dose‐limiting effect on treatment…
Abstract This review highlights the etiology, assessment, and management of unintentional weight loss in patients with pancreatic cancer and provides…
Abstract Rationale: The appetite-stimulating properties of cannabis are well documented and have been predominantly attributed to the hyperphagic activity of…
Abstract The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and…